GBP7.75
1.90% yesterday
London, Nov 15, 05:35 pm CET
ISIN
GB00BN4HT335
Symbol
INDV
Sector
Industry

Indivior Stock price

GBP7.75
+1.90 32.48% 1M
-6.10 44.04% 6M
-4.10 34.60% YTD
-5.42 41.15% 1Y
-3.89 33.42% 3Y
+5.68 274.94% 5Y
+0.57 7.95% 10Y
London, Closing price Fri, Nov 15 2024
-0.15 1.90%
ISIN
GB00BN4HT335
Symbol
INDV
Sector
Industry

Key metrics

Market capitalization GBP1.01b
Enterprise Value GBP987.50m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.06
P/S ratio (TTM) P/S ratio 1.09
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 9.91%
Revenue (TTM) Revenue GBP933.29m
EBIT (operating result TTM) EBIT GBP192.79m
Free Cash Flow (TTM) Free Cash Flow GBP-207.28m
Cash position GBP237.07m
EPS (TTM) EPS GBP-0.02
P/E forward 13.08
P/S forward 1.14
EV/Sales forward 1.11
Short interest 230.00%
Show more

Is Indivior a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Indivior Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Indivior forecast:

8x Buy
100%

Analyst Opinions

8 Analysts have issued a Indivior forecast:

Buy
100%

Financial data from Indivior

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
933 933
10% 10%
100%
- Direct Costs 230 230
45% 45%
25%
737 737
7% 7%
79%
- Selling and Administrative Expenses 426 426
49% 49%
46%
- Research and Development Expense 85 85
2% 2%
9%
219 219
195% 195%
23%
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 193 193
177% 177%
21%
Net Profit -1.13 -1.13
99% 99%
0%

In millions GBP.

Don't miss a Thing! We will send you all news about Indivior directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom.

Head office United Kingdom
CEO Mark Crossley
Employees 1,164
Founded 2014
Website indivior.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today